Inventor · disambiguated record
Jane Marie Lundbeck
Also filed as: LUNDBECK JANE M · LUNDBECK JANE MARIE
24 granted patents·3 pending applications·861 citations·filing 1993–2013
97Inventor score
Files withNOVO NORDISK AS16DORWALD FLORENCIO ZARAGOZA2HOHLWEG ROLF2BRITISH TECH GROUP INT1HIGH POINT PHARMACEUTICALS LLC1
Top patents by PatentIndex Score
27 records- 0198US7192952B2Heterocyclic compounds that are inhibitors of the enzyme DPP-IVNOVO NORDISK AS·Filed 2005·Granted Mar 20, 2007·115 cites·3 claims
- 0298US6869947B2Heterocyclic compounds that are inhibitors of the enzyme DPP-IVNOVO NORDISK AS·Filed 2002·Granted Mar 22, 2005·177 cites·53 claims
- 0397US6645995B2Therapeutically active and selective heterocyclic compounds that are inhibitors of the enzyme DPP-IVNOVO NORDISK AS·Filed 2002·Granted Nov 11, 2003·72 cites·12 claims
- 0497US6380398B2Therapeutically active and selective heterocyclic compounds that are inhibitors of the enzyme DPP-IVNOVO NORDISK AS·Filed 2001·Granted Apr 30, 2002·127 cites·17 claims
- 0596US7235538B2Heterocyclic compounds, which are inhibitors of the enzyme DPP-IVNOVO NORDISK AS·Filed 2003·Granted Jun 26, 2007·120 cites·10 claims
- 0692US6590118B1Aromatic compoundsNOVO NORDISK AS·Filed 2000·Granted Jul 8, 2003·24 cites·9 claims
- 0790US7598391B2Heteroaryl-ureas and their use as glucokinase activatorsNOVO NORDISK AS·Filed 2006·Granted Oct 6, 2009·14 cites·74 claims
- 0888US7872139B2Heteroaryl-ureas and their use as glucokinase activatorsNOVO NORDISK AS·Filed 2008·Granted Jan 18, 2011·10 cites·51 claims
- 0987US8344001B2Heterocyclic H3 antagonistsHIGH POINT PHARMACEUTICALS LLC·Filed 2008·Granted Jan 1, 2013·10 cites·36 claims
- 1087US7851636B2Heteroaryl-ureas and their use as glucokinase activatorsNOVO NORDISK AS·Filed 2010·Granted Dec 14, 2010·8 cites·20 claims
- 1186USRE45183EHeteroaryl-ureas and their use as glucokinase activatorsNOVO NORDISK AS·Filed 2013·Granted Oct 7, 2014·7 cites·52 claims
- 1286US8263634B2Heteroaryl-ureas and their use as glucokinase activatorsMURRAY ANTHONY·Filed 2010·Granted Sep 11, 2012·8 cites·12 claims
- 1385US6046214AHeterocyclic compoundsNOVO NORDISK AS·Filed 1998·Granted Apr 4, 2000·43 cites·34 claims
- 1481US5952363APyrrolidine compounds useful in the treatment of diabetesNOVO NORDISK AS·Filed 1998·Granted Sep 14, 1999·25 cites·11 claims
- 1573US8394842B2Benzothiazoles having histamine H3 receptor activityDORWALD FLORENCIO ZARAGOZA·Filed 2007·Granted Mar 12, 2013·2 cites·13 claims
- 1672US5328917APiperidine compounds for treating anoxia, cerebral ischemia migraine or epilepsyNOVO NORDISK AS·Filed 1993·Granted Jul 12, 1994·25 cites·10 claims
- 1771US8501739B2MedicamentsHOHLWEG ROLF·Filed 2006·Granted Aug 6, 2013·2 cites·13 claims
- 1870US6177443B14,5,6,7-tetrahydro-thieno[3, 2-C]pyridine derivatives, their preparation and useNOVO NORDISK AS·Filed 1998·Granted Jan 23, 2001·45 cites·45 claims
- 1958US6071932ACarbazolypiperines as GABA uptake inhibitorsBRITISH TECH GROUP INT·Filed 1996·Granted Jun 6, 2000·17 cites·8 claims
- 2053US5834482AHeterocyclic chemistryNOVO NORDISK AS·Filed 1996·Granted Nov 10, 1998·6 cites·7 claims
- 2149US8318927B26-(4-cyclopropylpiperazin-1-yl)-2′-methyl-[3, 4′]-bipyridine and its uses as a medicamentLUNDBECK JANE MARIE·Filed 2007·Granted Nov 27, 2012·0 cites·10 claims
- 2248US8772285B2Benzothiazoles having histamine H3 receptor activityDORWALD FLORENCIO ZARAGOZA·Filed 2012·Granted Jul 8, 2014·0 cites·12 claims
- 2346US8846677B2MedicamentsHOHLWEG ROLF·Filed 2012·Granted Sep 30, 2014·0 cites·8 claims
- 2446US6090797A4,5,6,7-tetrahydro-thieno(2,3-C)pyridine derivativesNOVO NORDISK AS·Filed 1999·Granted Jul 18, 2000·4 cites·26 claims
- 2545US2003186944A1Novel aromatic compoundsFiled 2003·Application pending·0 cites
- 2644US2002161001A1Heterocyclic compounds, which are inhibitors of the enzyme DPP-IVFiled 2001·Application pending·0 cites
- 2741US2003199528A1Hetrocyclic compounds that are inhibitors of the enzyme DPP-IVFiled 2003·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jane Marie Lundbeck files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →